PMID: 8606326Feb 1, 1996Paper

Salmeterol: a study by prescription-event monitoring in a UK cohort of 15,407 patients

Journal of Clinical Epidemiology
R D MannL Wilton

Abstract

To examine the safety of the long-acting beta2-agonist, salmeterol, in general medical practice in the U.K. In Prescription-Event Monitoring (PEM) the exposure data are derived from prescriptions confidentially provided by the Prescription Pricing Authority. Outcome data are obtained by questionnaires (green forms) on which prescribing medical practitioners recorded event (safety) data. Additional information is obtained from the patients' lifetime clinical records, from follow-up of all pregnancies, and from death certificates. PEM provides an observational cohort study in which there is no interference with the medical decision on which drug is prescribed for individual patients. A total of 15,407 patients were given salmeterol and observed for a minimum of 1 year. Headache, tremor, and palpitations were associated with the use of salmeterol. No unexpected major adverse events were noted, although in this study there was a total of 1022 deaths. Of these, 73 were due to asthma, but only 39 of these patients were taking salmeterol in the last month of life. All of these deaths appear on careful examination of the clinical records to have been due to natural causes, although in a minority (four, 10%) of the group of 39 subjects,...Continue Reading

References

Oct 1, 1988·BMJ : British Medical Journal·W H InmanC J Speirs

❮ Previous
Next ❯

Citations

Jul 3, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Rachael L DiSantostefanoCourtney Crim
Jan 5, 2002·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·S Shrewsbury, C Hallett
Feb 25, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·R A Nathan
Mar 20, 2001·Thorax·C Nelson-Piercy
Sep 10, 1998·American Journal of Respiratory and Critical Care Medicine·S F LanesC E Wentworth
Jul 5, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·R J Hancox, D R Taylor
Jan 23, 2016·The Lancet. Respiratory Medicine·Lies LahousseGuy G Brusselle
Jan 3, 2012·Pulmonary Pharmacology & Therapeutics·Mario Cazzola, Maria Gabriella Matera
Feb 1, 2011·Clinics in Chest Medicine·Vanessa E Murphy, Peter G Gibson
Sep 29, 2011·Birth Defects Research. Part A, Clinical and Molecular Teratology·Sherif EltonsyLucie Blais
Mar 5, 2003·Expert Opinion on Pharmacotherapy·Mike ThomasDavid Price
Jul 2, 2003·Expert Opinion on Pharmacotherapy·Pascal DemolyJean-Pierre Daures
Apr 16, 2013·Pulmonary Pharmacology & Therapeutics·M Miraglia del GiudiceL Perrone
Apr 29, 1998·Chest·R H MooreB F Dickey
Oct 1, 2007·Therapeutic Advances in Respiratory Disease·Mario Cazzola, Maria Gabriella Matera
Jun 30, 2011·The Annals of Pharmacotherapy·Angelina LimJohnson George
Sep 22, 2005·The Annals of Pharmacotherapy·Linda M Spooner, Jacqueline L Olin
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·N DunnR D Mann
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·K Kubota
Jun 1, 2013·Obstetric Medicine·Warwick Giles, Vanessa Murphy
May 23, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·R M Martin, S Shakir
Sep 8, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Milind P SovaniAnne E Tattersfield
Jan 9, 2019·The Cochrane Database of Systematic Reviews·Joseph Pryce, Paul Hine
May 23, 2012·Pharmacological Reviews·Mario CazzolaM Gabriella Matera
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Michael J AbramsonE Haydn Walters
May 19, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rachael L DiSantostefano, Kourtney J Davis
Aug 23, 2001·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·S A Quadrelli, A Roncoroni
Apr 12, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Lynda V Wilton, Saad A Shakir
Mar 9, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Catherine M Jackson, Brian Lipworth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.